Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-12-03

FDA Approved: OLANZAPINE — Supplemental Application (Torrent Pharmaceuticals Limited)

View source ↗

Summary

FDA approved a supplemental application for olanzapine from Torrent Pharmaceuticals Limited (ANDA 091415), expanding access to a generic olanzapine product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • olanzapine (olanzapine)

Snippet

SUPPL AP for OLANZAPINE (OLANZAPINE)